首页> 外国专利> HOWEVER, AWESOME ANTI-DISEASE TO HUMANE TSLP RECEPTORS

HOWEVER, AWESOME ANTI-DISEASE TO HUMANE TSLP RECEPTORS

机译:但是,对于人类TSLP受体而言,真是令人震惊的疾病

摘要

[Problem] To provide an anti-human TSLP receptor antibody that specifically binds to human TSLP receptor and inhibits an action of human TSLP through human TSLP receptor. [Means for Solution] An anti-human TSLP receptor antibody had been studied by the present inventors, and an anti-human TSLP receptor antibody comprising a heavy chain variable region consisting of the amino acid sequence of amino acid numbers 1 to 118 of SEQ ID NO: 1 and a light chain variable region consisting of the amino acid sequence of amino acid numbers 1 to 108 of SEQ ID NO: 3 was provided. It was revealed that the anti-human TSLP receptor antibody inhibits expression of TARC mRNA induced by TSLP and production of MDC proteins, and suppressed an allergic reaction in a monkey Ascaris antigen sensitization model, and then the present invention was completed.
机译:[问题]提供与人TSLP受体特异性结合并通过人TSLP受体抑制人TSLP作用的抗人TSLP受体抗体。 [解决方案]本发明人已经研究了抗人TSLP受体抗体,并且该抗人TSLP受体抗体包含重链可变区,该重链可变区由SEQ ID NO:1的氨基酸编号1至118的氨基酸序列组成提供了NO:1和由SEQ ID NO:3的氨基酸编号1至108的氨基酸序列组成的轻链可变区。结果表明,在猴A虫抗原致敏模型中,抗人TSLP受体抗体抑制了由TSLP诱导的TARC mRNA的表达和MDC蛋白的产生,并抑制了过敏反应,从而完成了本发明。

著录项

  • 公开/公告号DK3031913T3

    专利类型

  • 公开/公告日2019-05-20

    原文格式PDF

  • 申请/专利权人 ASTELLAS PHARMA INC.;

    申请/专利号DK20140833804T

  • 申请日2014-08-08

  • 分类号C12N15;A61K39/395;A61P11/06;C07K16/28;C07K16/46;C12N5/10;C12N15/09;C12P21/08;

  • 国家 DK

  • 入库时间 2022-08-21 12:02:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号